Perceptions of dengue risk and acceptability of a dengue vaccine in residents of Puerto Rico

Dengvaxia is the first dengue vaccine recommended in the United States (U.S.). It is recommended for children aged 9–16 y with laboratory-confirmed previous dengue infection and living in areas where dengue is endemic. We conducted focus groups with parents and in-depth interviews with key informant...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Coral Rosado-Santiago, Carmen L. Pérez-Guerra, Nicole M. Vélez-Agosto, Claudia Colón-Burgos, Karla M. Marrero-Santos, Susanna K. Partridge, Amy E. Lockwood, Cathy Young, Steve H. Waterman, Gabriela Paz-Bailey, Iris Cardona-Gerena, Angel Rivera, Laura E. Adams, Joshua M. Wong
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Taylor & Francis Group 2024-12-01
סדרה:	Human Vaccines & Immunotherapeutics
נושאים:	Dengue vaccine Dengvaxia vaccine acceptability qualitative methods Puerto Rico
גישה מקוונת:	https://www.tandfonline.com/doi/10.1080/21645515.2024.2323264
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!